
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Urine Phenylacetylglutamine Determination in Patients with Hyperphenylalaninemia
Fernando Andrade, Ainara Cano, María Unceta Suárez, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3674-3674
Open Access | Times Cited: 7
Fernando Andrade, Ainara Cano, María Unceta Suárez, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3674-3674
Open Access | Times Cited: 7
Showing 7 citing articles:
Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure
Xiao Zong, Qin Fan, Qian Yang, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 4, pp. 2645-2653
Open Access | Times Cited: 29
Xiao Zong, Qin Fan, Qian Yang, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 4, pp. 2645-2653
Open Access | Times Cited: 29
Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights
Yaonan Song, Haoran Wei, Zhitong Zhou, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 1, pp. 31-45
Open Access | Times Cited: 7
Yaonan Song, Haoran Wei, Zhitong Zhou, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 1, pp. 31-45
Open Access | Times Cited: 7
Identification of metabolites reproducibly associated with Parkinson’s Disease via meta-analysis and computational modelling
Xi Luo, Yanjun Liu, Alexander Balck, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Xi Luo, Yanjun Liu, Alexander Balck, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Multimodal Metabolomic Analysis Reveals Novel Metabolic Disturbances in Adults With Early Treated Phenylketonuria
Yann Dos Santos, Patrick Emond, Ida Vanessa Döederlein Schwartz, et al.
JIMD Reports (2025) Vol. 66, Iss. 2
Open Access
Yann Dos Santos, Patrick Emond, Ida Vanessa Döederlein Schwartz, et al.
JIMD Reports (2025) Vol. 66, Iss. 2
Open Access
Impact of Phenylketonuria on the Serum Metabolome and Plasma Lipidome: A Study in Early-Treated Patients
J. C. van der Weerd, Annemiek M. J. van Wegberg, Theo Boer, et al.
Metabolites (2024) Vol. 14, Iss. 9, pp. 479-479
Open Access | Times Cited: 1
J. C. van der Weerd, Annemiek M. J. van Wegberg, Theo Boer, et al.
Metabolites (2024) Vol. 14, Iss. 9, pp. 479-479
Open Access | Times Cited: 1
Causal associations of BAFF-R on IgD+ CD24- immune cell trait with hepatocellular carcinoma and the mediating role of phenylacetylglutamate levels: a Mendelian randomization study
Xuan Zhu, Zongchao Qiu, Maochun Yang, et al.
Research Square (Research Square) (2024)
Open Access
Xuan Zhu, Zongchao Qiu, Maochun Yang, et al.
Research Square (Research Square) (2024)
Open Access
Urinary phenylacetylglutamine as a possible biomarker for central nervous system disorders in forensic autopsy cases
Natsuki Ikematsu, Kenji Hara, Brian Waters, et al.
Legal Medicine (2023) Vol. 64, pp. 102274-102274
Closed Access | Times Cited: 1
Natsuki Ikematsu, Kenji Hara, Brian Waters, et al.
Legal Medicine (2023) Vol. 64, pp. 102274-102274
Closed Access | Times Cited: 1